[title missed]

Corresponding author: zhaofenqin, zfqlzh@163.com

DOI: 10.12201/bmr.202501.00040

•  

  Abstract: Ovarian fibrosis is one of the main causes of ovarian dysfunction and is characterized by excessive proliferation of ovarian fibroblasts and accumulation of extracellular matrix (ECM). As a late manifestation of ovarian injury, the research on the therapeutic targets of ovarian fibrosis is more limited to animal experiments, and there are no effective methods and drugs for anti-ovarian fibrosis in clinical practice. Therefore, it is of great significance to study the pathogenesis and treatment progress of ovarian fibrosis. This article reviews the recent research on the molecular mechanism of ovarian fibrosis from the aspects of promoting fibrosis and inhibiting fibrosis, and summarizes the relationship between ovarian diseases and fibrosis and the current treatment methods for ovarian fibrosis. It provides a theoretical basis for the research and development of new drugs for the treatment of ovarian fibrosis.

  Key words: ovarian fibrosis; extracellular matrix; transforming growth factor β; Research Progress

  Submit time: 15 January 2025

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• HANG Yu-jie, CHEN Kun, LIU Qian-yu, ZHANG Yu-bin, XU Liang, ZHANG Li-xue, BAI Jing-ya▲. Research progress of biomarkers for renal fibrosis. 2024. doi: 10.12201/bmr.202411.00072

  Guan Wei, Xue Xiaoming. Progress of Trditional Chinese Medicine Targeting Alveolar Epithelial Cell Senescence in the Treatment of Pulmonary Fibrosis. 2025. doi: 10.12201/bmr.202506.00012

  任前军, Lisu, Chenyuqing, luweiqing, mengxiaozu, Zhaoxiaofang, Liuxudong. Research Progress of Granulocyte Colony Stimulating Factor in the Treatment of Liver Failure. 2025. doi: 10.12201/bmr.202505.00003

  李洛华. . 2025. doi: 10.12201/bmr.202506.00031

  Li Junyuan, Zhang Bin, He Yong. . 2024. doi: 10.12201/bmr.202406.00011

  guoxiaochen, wangpengfei, chenxiu, wuxinyao, zouchunpengchun, 徐茂晟. The value of SWE in early liver and kidney fibrosis in MAFLD. 2024. doi: 10.12201/bmr.202409.00010

  DuYuPeng, LinYan. Exploration of Diagnostic and Treatment Experience in Two Cases of Idiopathic Retroperitoneal Fibrosis. 2024. doi: 10.12201/bmr.202410.00077

  Lin ZhiFeng, ZHANG ChuJian, LIU Dong, Kong YiJing. To explore the optimal intervention time of 1.25 (OH) 2D3 to protect renal interstitialfibrosis based on NF-κB inflammatory pathway. 2025. doi: 10.12201/bmr.202504.00063

  Cai Xudong. Macrophage Polarization Affects Chronic Kidney Disease:Based on Theory of “Harmful Hyperactivity and Responding Inhibition”. 2024. doi: 10.12201/bmr.202407.00027

  Adipose vascular matrix fraction combined with platelet-rich fibrin in the treatment of chronic skin ulcers. 2025. doi: 10.12201/bmr.202510.00022

• ID	Submit time	Number	Download
  1	2025-01-02	10.12201/bmr.202501.00040V1	Download

• Public  Anonymous  To author only Submit Comments